Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
AstraZeneca
UBS
McKesson
Mallinckrodt
Moodys
Fuji
Healthtrust
Accenture

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205175

« Back to Dashboard

NDA 205175 describes ECOZA, which is a drug marketed by Chemo Research Sl and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the ECOZA profile page.

The generic ingredient in ECOZA is econazole nitrate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the econazole nitrate profile page.
Summary for 205175
Tradename:ECOZA
Applicant:Chemo Research Sl
Ingredient:econazole nitrate
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 205175
Ingredient-typeAzoles
Medical Subject Heading (MeSH) Categories for 205175
Suppliers and Packaging for NDA: 205175
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ECOZA econazole nitrate AEROSOL, FOAM;TOPICAL 205175 NDA Exeltis USA Dermatology, LLC 23710-100 23710-100-10 1 CAN in 1 CARTON (23710-100-10) > 10 g in 1 CAN
ECOZA econazole nitrate AEROSOL, FOAM;TOPICAL 205175 NDA Exeltis USA Dermatology, LLC 23710-100 23710-100-70 1 CAN in 1 CARTON (23710-100-70) > 70 g in 1 CAN

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength1%
Approval Date:Oct 24, 2013TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Aug 8, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Jan 16, 2018Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF ALLEVIATING A SKIN CONDITION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
Fish and Richardson
Johnson and Johnson
Moodys
Teva
Cipla
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.